JBC
ATEX icon

Jefferson Bridge Capital’s Anterix ATEX Stock Holding History

Jefferson Bridge Capital’s Portfolio ATEX Stock Details ATEX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.33M Hold
12,950
– – 1.16% 31
2026
Q1 		$495K Hold
12,950
– – 0.49% 48
2025
Q4 		$283K Buy
+12,950
New +$269K 0.28% 52

Other funds holding ATEX

KMC
Kirr Marbach & Co Columbus, Indiana $594M AUM 34% 1-Year Est. Return
OCA
OpenArc Corporate Advisory Atlanta, Georgia $8.41B AUM
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
TD Asset Management
TD Asset Management Toronto, Ontario, Canada $115B AUM 41.58% 1-Year Est. Return
CCIA
Campbell & Co Investment Adviser Baltimore, Maryland $1.91B AUM 17.57% 1-Year Est. Return
WIC
Woodmont Investment Counsel Nashville, Tennessee $1.83B AUM 25.91% 1-Year Est. Return
GS
GWN Securities Palm Beach Gardens, Florida $598M AUM 32.4% 1-Year Est. Return
FIC
FCG Investment Company Germantown, Tennessee $289M AUM
WW
Waterfront Wealth Overland Park, Kansas $645M AUM 27.59% 1-Year Est. Return

Jefferson Bridge Capital's ATEX Position: Q2 2026 in Review

Jefferson Bridge Capital held its Anterix (ATEX) position steady in Q2 2026 at 12,950 shares worth $1.33M. The position accounts for 1.16% of the portfolio, ranked #31.

Jefferson Bridge Capital first reported a position in ATEX in Q4 2025 and has held it in 3 quarters since. 46 funds tracked by Wall St. Rank hold ATEX as of Q2 2026.

  • Jefferson Bridge Capital held 12,950 shares of Anterix worth $1.33M as of Q2 2026.
  • Jefferson Bridge Capital left its Anterix share count unchanged in Q2 2026.
  • Anterix made up 1.16% of Jefferson Bridge Capital's portfolio in Q2 2026, its #31 holding.
  • Jefferson Bridge Capital first reported a position in Anterix in Q4 2025 and has held it in 3 quarters since.
  • 46 funds tracked by Wall St. Rank held Anterix as of Q2 2026.

Based on Jefferson Bridge Capital's 13F filing for Q2 2026, filed 21 Jul 2026.